Janus Capital Management LLC Sells 45,621 Shares of Walgreens Boots Alliance, Inc. (WBA)

Janus Capital Management LLC trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 48.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,334 shares of the pharmacy operator’s stock after selling 45,621 shares during the period. Janus Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $4,097,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of WBA. Nordea Investment Management AB raised its holdings in Walgreens Boots Alliance by 26.5% during the 1st quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock valued at $760,267,000 after buying an additional 1,917,082 shares during the period. Wellington Management Group LLP raised its holdings in Walgreens Boots Alliance by 5.9% during the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after buying an additional 1,824,300 shares during the period. TIAA CREF Investment Management LLC raised its holdings in Walgreens Boots Alliance by 22.4% during the 1st quarter. TIAA CREF Investment Management LLC now owns 5,269,500 shares of the pharmacy operator’s stock valued at $437,632,000 after buying an additional 962,959 shares during the period. UBS Asset Management Americas Inc. raised its holdings in Walgreens Boots Alliance by 22.9% during the 1st quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock valued at $407,982,000 after buying an additional 914,888 shares during the period. Finally, Prudential Financial Inc. raised its holdings in Walgreens Boots Alliance by 53.0% during the 1st quarter. Prudential Financial Inc. now owns 2,211,112 shares of the pharmacy operator’s stock valued at $183,632,000 after buying an additional 766,200 shares during the period. 60.18% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now directly owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 13.50% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This story was first posted by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another site, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this story can be read at https://www.tickerreport.com/banking-finance/2886963/janus-capital-management-llc-sells-45621-shares-of-walgreens-boots-alliance-inc-wba.html.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 1.149% during mid-day trading on Tuesday, reaching $83.225. The company’s stock had a trading volume of 3,328,319 shares. The company has a market capitalization of $89.06 billion, a price-to-earnings ratio of 21.016 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $88.00. The company’s 50 day moving average price is $80.85 and its 200-day moving average price is $82.05.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The business had revenue of $30.12 billion for the quarter, compared to analysts’ expectations of $29.72 billion. During the same quarter last year, the firm earned $1.18 earnings per share. The business’s revenue was up 2.1% on a year-over-year basis. Analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th will be issued a dividend of $0.40 per share. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date is Wednesday, August 16th. This represents a $1.60 annualized dividend and a dividend yield of 1.94%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 40.30%.

Walgreens Boots Alliance declared that its Board of Directors has authorized a stock repurchase program on Thursday, June 29th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to purchase up to 5.9% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.

Several analysts recently weighed in on WBA shares. Needham & Company LLC upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 price target on the stock in a report on Friday, June 30th. Pivotal Research set a $85.00 price target on Walgreens Boots Alliance and gave the company a “hold” rating in a report on Sunday, July 2nd. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, June 14th. Goldman Sachs Group, Inc. (The) restated a “neutral” rating and set a $77.00 price target (down previously from $89.00) on shares of Walgreens Boots Alliance in a report on Wednesday, June 28th. Finally, Jefferies Group LLC cut their price objective on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, May 31st. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $91.81.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.